---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-047040"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2025-05-12T23:59:59+00:00"
generated_at: "2026-05-21T23:10:14.070007+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Collegium enters $25M accelerated share repurchase; 692,281 shares initially delivered

## Summary
- ASR with Jefferies for $25M; part of $150M repurchase program authorized Jan 2024.
- Initial delivery of 692,281 shares (approx 80% of expected) at $28.89 closing price on May 9.
- Final settlement expected by Q3 2025; shares based on volume-weighted average price.
- As of March 31, 2025, Collegium had ~32.1M shares outstanding.

## SEC filing metadata
- accession: 0001104659-25-047040
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2025-05-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465925047040/0001104659-25-047040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465925047040/tm2514636d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-047040
- JSON: https://secwatch.observer/filing/0001104659-25-047040.json
- Plain text: https://secwatch.observer/filing/0001104659-25-047040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.